Results 101 to 110 of about 4,655,222 (236)

Role of Prothrombin Complex Concentrates in Reversal of Direct Oral Anticoagulant Effects

open access: yesBezmiâlem Science
Objective: The aim of this study is to evaluate the efficacy and safety of four-factor prothrombin complex concentrate in reversing the anticoagulant effect in patients presenting to the emergency department with bleeding associated with direct oral ...
Gökhan ERSUNAN   +4 more
doaj   +1 more source

A Study on the Effects of Dırect Factor Xa Inhibitors and Direct Thrombin Inhibitors on Human Primary Chondrocyte Cultures [PDF]

open access: yes, 2019
Aim:This study investigates the effects of two direct factor Xa inhibitors, apixaban and rivaroxaban, and a direct thrombin inhibitor, dabigatran, on human primary chondrocyte cultures.Materials and Methods:Monolayer cultured chondrocytes were prepared ...
Duygu YASAR SIRIN   +6 more
core  

Non-Amidine-Containing 1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa with Potent Anticoagulant and Antithrombotic Activity

open access: yes, 2016
Non-Amidine-Containing 1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa with Potent Anticoagulant and Antithrombotic ...
Michael R. Wiley (189278)   +20 more
core   +1 more source

Retrospective evaluation of outcomes in dogs with non‐associative immune‐mediated haemolytic anaemia treated with rivaroxaban as a sole or adjunctive thromboprophylaxis agent: 34 cases (2018‐2024)

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives To describe clinical outcomes, thromboembolic and haemorrhagic complications, and treatment characteristics in dogs with non‐associative immune‐mediated haemolytic anaemia treated with rivaroxaban at a UK referral hospital. Materials and Methods Retrospective descriptive study of dogs diagnosed with non‐associative immune‐mediated haemolytic
S. Conway, L. Jenkins, J. Reeve
wiley   +1 more source

Andexanet alfa for the reversal of factor Xa inhibitors.

open access: yes, 2019
Andexanet alfa is a recombinant modified factor Xa protein that has been developed to reverse factor Xa inhibitors. Since May 2018, the FDA has approved its utilization in patients treated with apixaban and rivaroxaban in case of life-threatening or ...
Dincq, A S   +19 more
core   +1 more source

How Awareness of Orthographic Transparency Benefits the Lexical Encoding of Second Language Vowels

open access: yesLanguage Learning, EarlyView.
Abstract We investigated the influence of orthographic transparency, and learners’ awareness of it, on the second language (L2) phonolexical encoding of Brazilian Portuguese (BP) mid‐vowel contrasts. In BP, accent marks indicate vowel quality (mid‐closed vs.
Hunter Brakovec, Isabelle Darcy
wiley   +1 more source

Oral factor Xa inhibitors in acute coronary syndromes

open access: yes, 2009
Factor Xa inhibitors, a new class of oral anticoagulants, have been evaluated in the phase II ATLAS ACS-TIMI 46 and APPRAISE trials. addition of these agents to standard therapy has tended to reduce the incidence of adverse cardiovascular events at the ...
Gregory Y. H. Lip   +5 more
core   +1 more source

Extending the Farquhar–von Caemmerer–Berry photosynthesis model to account for various photorespiratory bypasses

open access: yesNew Phytologist, EarlyView.
We extend a widely used C3‐photosynthesis model to account for various photorespiratory bypasses, thereby, providing a useful resource and framework that enforces future novel bypass work and scrutinize if the results go counter to theory. Our model analyses show that of the 17 published bypass pathways, full‐decarboxylating bypasses (that have been ...
Xinyou Yin   +3 more
wiley   +1 more source

Comparing Direct Factor Xa Inhibitors and Warfarin in the Prevention of Stroke in Patients with Atrial Fibrillation [PDF]

open access: yes, 2016
Objective: To evaluate the overall efficacy, advantages, and disadvantages of treatment with direct factor Xa inhibitors as compared to warfarin in the prevention of stroke in patients with atrial fibrillation.
Lof, Alessandra, Pillai, Stephanie
core  

Oral Soft Tissue Biopsy in Patients Receiving Direct Oral Anticoagulants: A Prospective Cohort Study on Bleeding Outcomes

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Direct oral anticoagulants (DOACs) are the first‐line therapy for stroke prevention in non‐valvular atrial fibrillation and venous thromboembolism. While evidence supports their continuation during routine dental procedures such as tooth extractions, data on oral soft tissue biopsies remain limited.
Rossana Izzetti   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy